MG
BRKR icon

Michael Gelband’s Bruker BRKR Stock Holding History

Michael Gelband’s Portfolio BRKR Stock Details BRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30,716
Closed -$998K – 1570
2025
Q3 		$998K Sell
30,716
-37,942
-55% -$1.35M 0.01% 960
2025
Q2 		$2.83M Buy
+68,658
New +$2.65M 0.02% 616
2024
Q1 		– Sell
-79,297
Closed -$5.83M – 1505
2023
Q4 		$5.83M Sell
79,297
-228,616
-74% -$14.6M 0.04% 314
2023
Q3 		$19.2M Buy
307,913
+234,139
+317% +$15.8M 0.18% 103
2023
Q2 		$5.45M Sell
73,774
-5,894
-7% -$449K 0.04% 422
2023
Q1 		$6.28M Buy
79,668
+76,546
+2,452% +$5.52M 0.05% 434
2022
Q4 		$213K Buy
+3,122
New +$198K ﹤0.01% 1444
2022
Q3 		– Sell
-86,636
Closed -$5.44M – 1894
2022
Q2 		$5.44M Buy
86,636
+71,135
+459% +$4.36M 0.07% 379
2022
Q1 		$997K Sell
15,501
-21,114
-58% -$1.44M 0.01% 1164
2021
Q4 		$3.07M Sell
36,615
-4,059
-10% -$325K 0.03% 596
2021
Q3 		$3.18M Sell
40,674
-20,625
-34% -$1.71M 0.04% 551
2021
Q2 		$4.66M Buy
61,299
+52,597
+604% +$3.67M 0.05% 386
2021
Q1 		$559K Sell
8,702
-85,452
-91% -$5.13M 0.01% 1266
2020
Q4 		$5.1M Buy
94,154
+85,942
+1,047% +$4.12M 0.05% 242
2020
Q3 		$326K Sell
8,212
-38,789
-83% -$1.62M 0.01% 1242
2020
Q2 		$1.91M Buy
47,001
+40,823
+661% +$1.61M 0.05% 445
2020
Q1 		$222K Sell
6,178
-7,738
-56% -$359K 0.01% 750
2019
Q4 		$709K Buy
+13,916
New +$663K 0.01% 689
2019
Q2 		– Sell
-23,800
Closed -$915K – 1112
2019
Q1 		$915K Buy
+23,800
New +$859K 0.07% 205

Other funds holding BRKR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCA
Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
LCOV
London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return

Michael Gelband's BRKR Position: Q4 2025 in Review

Michael Gelband sold out of Bruker (BRKR) in Q4 2025, closing a stake of 30,716 shares — an estimated $998K sold.

Michael Gelband first reported a position in BRKR in Q1 2019 and held it in 19 quarters. The position peaked at $19.2M in Q3 2023. 355 funds tracked by Wall St. Rank hold BRKR as of Q4 2025.

  • Michael Gelband reported no remaining Bruker position as of Q4 2025 after selling out during the quarter.
  • Michael Gelband sold 30,716 Bruker shares in Q4 2025, an estimated $998K.
  • Michael Gelband first reported a position in Bruker in Q1 2019 and held it in 19 quarters.
  • Michael Gelband's Bruker position peaked at $19.2M in Q3 2023.
  • 355 funds tracked by Wall St. Rank held Bruker as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.